Form 4: Zomedica Corp. VP of Sales, Russell Kevin Klass, Reports Stock Sale
SEC Form 4 Filing
Russell Kevin Klass, Vice President of Sales at Zomedica Corp., reports the sale of 299,993 shares of common stock at a weighted average price of $0.1551.
Summary
- On June 12, 2024, Russell Kevin Klass, the Vice President of Sales at Zomedica Corp., sold 299,993 shares of common stock.
- The shares were sold at a weighted average price of $0.1551.
- The price range for the sales was between $0.1520 and $0.1559.
- Following the transaction, Klass directly owns 2,000,050 shares of Zomedica Corp.
- This transaction was reported on a Form 4 filing with the SEC on June 13, 2024.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, reporting a stock sale by a company executive. It is neutral in tone and factual in nature.
Industry Context
Insider sales are a common occurrence and are publicly disclosed to maintain market transparency. The sale by the VP of Sales at Zomedica Corp. is now part of the public record.
Stakeholder Impact
- The sale of shares by a company executive may have a minor impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 06/12/2024 | Date of transaction: Russell Kevin Klass sold shares of Zomedica Corp. |
| 06/13/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.